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Smbp-2 is a novel transcription factor that was first identified through its interaction with the immunoglobulin Sm region
(Mizuta et al., 1993) and has been cloned by virtue of its binding to two 12-O-tetradecanoylphorbol-13-acetate-responsive
elements in the Epstein–Barr virus immediate-early BZLF1 promoter (Gulley et al., 1997). In this report, we examined the
effect of Smbp-2 overexpression on BZLF1 promoter activity. Overexpression of Smbp-2 in the B lymphocyte cell line BJAB
caused repression of the BZLF1 gene promoter. A 14-bp region that partially overlaps with a 12-O-tetradecanoylphorbol-
13-acetate-responsive element was required for maximal repression by Smbp-2, but some repression was also seen with a
minimal promoter containing only the BZLF1 promoter TATA box and an initiation site. A 30-bp fragment containing the 14-bp
region could transfer Smbp-2-mediated repression to heterologous promoters. Smbp-2 was found to associate with the basal
transcription factor TATA binding protein (TBP) and to disrupt the formation of a stable TBP–TFIIA–DNA complex on the
BZLF1 promoter TATA box and the adenovirus E1B promoter TATA box. Repression of the BZLF1 promoter by overexpressed
Smbp-2 was rescued by overexpression of the basal factor TFIIA. These results suggest that complete repression of the
BZLF1 promoter by Smbp-2 involves disruption of a functional TBP–TFIIA–TATA box complex and requires the 293 bp-to-279
bp region of the promoter. © 1999 Academic PressINTRODUCTION
Smbp-2 (also known as RIP-1 and Catf1) is a ubiqui-
ous protein that binds single-stranded DNA with 59-
hosphorylated guanine-rich sequences (Fukita et al.,
993; Mizuta et al., 1993; Sebastiani et al., 1995; Shieh et
l., 1995). The Smbp-2 cDNA was initially cloned using a
robe corresponding to the immunoglobulin Sm region,
ut there is no evidence that Smbp-2 is involved in
mmunoglobulin class switching. Other studies, however,
uggest that Smbp-2 is a transcription factor (Chen et al.,
997; Sebastiani et al., 1995; Shieh et al., 1995). Smbp-2
nd a truncated Smbp-2, designated glial factor 1 (GF-1),
ransactivate the JC virus (JCV) early and late promoters
n glial cells (Chen et al., 1997; Kerr and Khalili, 1991). The
at homolog of Smbp-2, Catf1, presumably transactivates
he atrial natriuretic factor (ANF) promoter through inter-
ction with a cis-acting myocyte-specific element (Se-
astiani et al., 1995). The hamster homolog Rip-1 binds to
tissue-specific element from the rat insulin II gene
romoter, but binding appears to minimally affect pro-
oter activity (Shieh et al., 1995).
Smbp-2 contains seven helicase motifs that are con-
erved among proteins involved in DNA replication, re-
air, and recombination (Koonin, 1992; Mizuta et al.,
993). Helicase activity has not been reported, but over-
xpression of Smbp-2 in JCV-infected glial cells nega-
ively affects viral DNA replication (Chen et al., 1997). In
1 To whom reprint requests should be addressed. Fax: (210) 567-6921.
-mail: montalvo@uthscsa.edu.ll rights of reproduction in any form reserved.ddition to the seven helicase motifs, Smbp-2 has a
ingle-stranded DNA-binding domain that contains a he-
ix-turn-helix motif of unknown significance, a nuclear
ocalization signal, and a carboxyl-terminus that is rich in
lutamine and proline residues.
Previous studies performed in our laboratory reported
he cloning of Smbp-2 from a HeLa cell expression library
sing probes corresponding to the ZIB and ZIC elements
n the Epstein–Barr virus (EBV) BZLF1 promoter (Gulley et
l., 1997). The EBV BZLF1 promoter directs transcription
f an immediate-early protein that plays an important
ole in the switch between viral latency and lytic replica-
ion. The ZI elements are a family of four sequence-
elated sites (ZIA–ZID) that are responsive to the phorbol
ster 12-O-tetradecanoylphorbol-13-acetate (TPA) (Flem-
ngton and Speck, 1990a). In the absence of TPA, some of
hese elements can function as cis-acting negative ele-
ents. In this report, we examine the role of Smbp-2 in
ZLF1 gene regulation and demonstrate that overex-
ression of Smbp-2 represses the BZLF1 promoter in an
BV-negative B cell line. A mechanism for Smbp-2-medi-
ted repression is proposed, and its effect on other viral
nd mammalian promoters is also examined.
RESULTS
mbp-2 represses the BZLF1 promoter in EBV-
egative BJAB cells
We previously reported the cloning of Smbp-2 using
robes corresponding to two TPA inducible elements,
1B and Z1C, in the BZLF1 promoter (Gulley et al., 1997).a
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161REPRESSION BY Smbp-2hree other laboratories have cloned the Smbp-2 ho-
ologs from mouse, rat, and hamster (Fukita et al., Se-
astiani et al., 1995; Shieh et al., 1995). Binding studies
ndicate that Smbp-2 binds to guanine-rich single-
tranded DNA, but a consensus sequence binding site
as not been identified. Because Smbp-2 has been re-
orted to function as a transcription factor, experiments
ere first carried out to determine the effect of overex-
ressed Smbp-2 on BZLF1 promoter activity. A plasmid
ontaining the Smbp-2 cDNA downstream of the CMV
mmediate-early 1 promoter (pCMVSm) was cotrans-
ected into BJAB cells together with CAT reporter plas-
ids containing BZLF1 promoter fragments previously
sed to map cis-acting regulatory elements (Montalvo et
l., 1995, 1991; Wang et al., 1997). The reporter plasmids
ontained either 222, 130, 93, 79, or 40 bp upstream of
he putative transcription start site. A map of the BZLF1
romoter and deletion plasmids is shown in Fig. 1A.
urprisingly, overexpression of Smbp-2 caused repres-
ion of the BZLF1 promoter in BJAB cells (Fig. 1B). The
222 bp plasmid was repressed 8-fold. Further repres-
ion (10-fold) was observed with the 2130 plasmid that
oes not contain the ZIA, ZIB, and Z1C elements. Similar
evels of repression were observed with the 293 plas-
id, which had additional deletions of the autoregulatory
III elements (Flemington and Speck, 1990b). In contrast,
nly 3- and 2.5-fold repression was seen with the 279
nd 240 deletion plasmids, respectively. The Z1D ele-
ent is deleted in the 279 plasmid, and the ZII element,
TPA- and anti-immunoglobulin-responsive element
Daibata et al., 1994; Flemington and Speck, 1990), is
eleted in the 240 plasmid construct. To determine
hether the minimal repression seen with the 279 and
40 plasmids was due to a guanine-rich sequence in
hese plasmids (SV; Fig. 1A), a 279 plasmid containing
utations of 4 bp within the SV site was tested in similar
xperiments. The mutant 279 plasmid was repressed at
imilar levels as the wild-type plasmid, suggesting that
he SV site does not contribute to Smbp-2 mediated
epression. Taken together, these results suggested that
verexpressed Smbp-2 represses BZLF1 promoter activ-
ty and that the repression is significantly affected by a
4-bp region between 293 bp and 279 bp.
mbp-2 represses a heterologous promoter
ontaining 30 bp of the BZLF1 promoter
Experiments were next carried to determine whether
he region between 293 bp and 279 bp of the BZLF1
romoter could transfer Smbp-2 mediated repression to
heterologous promoter. For these experiments, the
101 bp-to-271 bp region of the BZLF1 promoter (i.e.,
ncompassing the 14-bp region) was cloned upstream of
he herpes simplex virus thymidine kinase (tk) promoter,
nd the plasmids containing either one or three copies of
he 30-bp region of the BZLF1 promoter were transfected
nto BJAB cells with or without plasmids expressingmbp-2. The results of these experiments are shown in
ig. 2. The tk promoter was repressed slightly by over-
xpressed Smbp-2 (1.5-fold). A tk promoter containing
ne copy of the 30-bp region was repressed 4.2-fold,
hereas the tk promoter containing three copies of the
0-bp fragment was repressed 15-fold. Similar results
ere obtained with an enhancerless SV40 promoter con-
aining three copies of the 30-bp region (data not shown).
PA-induced BZLF1 promoter activity is also
epressed by Smbp-2
The BZLF1 promoter contains several TPA-responsive
lements that are presumably involved in virus reactiva-
ion (Flemington and Speck, 1990). TPA treatment of B
ell lines latently infected with EBV results in the activa-
ion of BZLF1 transcription. Experiments were next car-
ied out to determine whether overexpression of Smbp-2
lso affects activated transcription of BZLF1. For these
tudies, cotransfection experiments were carried out in
G75 cells, an EBV-negative B cell line that has previ-
usly been shown to be efficiently induced by TPA in
EAE transfections (Borras et al., 1996). In these exper-
ments, the basal activity of the transfected BZLF1 pro-
oter/reporter plasmid was considerably lower in DG75
ells than previously seen in transfected BJAB cells. In
ntreated cells, lower levels of CAT activity were seen in
G75 cells transfected with Smbp-2, but the degree of
epression was difficult to measure because expression
as extremely low (,1% CAT activity; Fig 3). In cells
reated with TPA, CAT activity increased 7- to 8-fold in
ells transfected with parental control plasmid, consis-
ent with previously published data (Borras et al., 1996).
n cells transfected with Smbp-2, there was an increase
n expression in TPA-treated cultures, but again, the
ncrease was difficult to measure because of the ex-
remely low levels of CAT expression in untreated Smbp-
-transfected cells. The relative levels of CAT activity in
mbp-2-transfected cells treated with TPA were similar to
hose seen in untreated control transfections. These re-
ults suggested that Smbp-2 can repress TPA-induced
ranscription of the BZLF1 promoter, but overexpression
f Smbp-2 is not sufficient to completely prevent TPA
nduction.
mbp-2 represses other promoters in BJAB cells
Squelching of general transcription factors (GTFs) by
verexpressed transcriptional transactivators or repres-
ors has been reported (reviewed in Cahill et al., 1994;
atesan et al., 1997). Repression by Smbp-2 of a minimal
ZLF1 promoter containing no apparent Smbp-2-binding
ites (i.e., 240 bp) suggested the sequestering of a GTF.
herefore, other promoters of both viral and cellular
rigin were tested in cotransfection experiments with
CMVSm or control pCMV. The viral promoters included
he adenovirus E1B promoter, the SV40 promoter, the
ytomegalovirus (CMV) immediate-early 1 gene (IE-1)
p
p
E
m
f
2
C
m
s
t
M
S
t
b
r
B
p
i
162 ZHANG, WANG, AND MONTALVOromoter, and the EBV Fp promoter. The mammalian
romoters tested were the immunoglobulin heavy chain
m promoter and the muscle creatine kinase (MCK) pro-
oter. All of the promoters tested were repressed ;2-
old to 3-fold (Fig. 4). The E1B promoter was repressed
-fold, the SV40 promoter was repressed 2.4-fold, the
MV IE-1 was repressed 1.7-fold, and the EBV Fp pro-
oter was repressed 2.6-fold, respectively. Similar re-
FIG. 1. (A) Schematic representation of the BZLF1 promoter. The ZI elem
ind either Sp1/Sp3, MEF2D, or both (Borras et al., 1996; Flemington and S
esponsive element that binds ATF1 (Daibata et al., 1994; Flemington and
ZLF1 gene product Zta (Flemington and Speck, 1990a). SI–SV are guanine
130, p93, p79, p40, and pm79 were cotransfected into EBV-negative BJAB
n “Materials and Methods.” Transfected cells were recovered and CAT aults were obtained with the mammalian promoters
ested. The Em promoter was repressed 2.5-fold, and the
CK promoter was repressed 2-fold, respectively.
mbp-2 binds TBP in vitro
GST pull-down experiments were next performed to de-
ermine whether there was an interaction between Smbp-2
a family of sequence-related A 1 T-rich elements responsive to TPA that
990b; Liu et al., 1997). The ZII element is a TPA- and anti-immunoglobulin-
1990a; Wang et al., 1997), and the ZIII elements are binding sites for the
gions in the promoter. (B) The BZLF1 promoter/CAT fusion plasmids p222,
mg) together with either pCMV (20 mg) or pCMVSm (20 mg) as described
as determined as described in “Materials and Methods.”ents are
peck, 1
Speck,
-rich re
cells (5
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163REPRESSION BY Smbp-2nd a GTF. Several human GTFs, including TAFp55, TFIIA,
FIIB, and TBP, were tested in pull-down experiments using
ST-Sm immobilized on glutathione beads. A known trans-
ctivator of BZLF1 promoter, ATF1, was also tested in these
xperiments (Wang et al., 1997). Of all the GTFs tested, only
BP bound to GST-Sm with strong affinity (Fig. 5). Weak
inding was observed with TAFp55. Under the same con-
itions, TFIIAa/bg, ATF1, and the luciferase control failed to
ind GST-Sm. No binding was detected with TFIIB, but the
n vitro translation of the full-length TFIIB product was very
nefficient in these experiments (data not shown). None of
he in vitro translated products, including TBP, bound to the
FIG. 2. Overexpression of Smbp-2 in BJAB cells caused repression of
eterologous promoters containing a 32-bp region of the BZLF1 pro-
oter. A 32-bp region spanning between the ZID and ZII elements was
nserted upstream of the herpes simplex thymidine kinase promoter as
escribed in “Materials and Methods.” BJAB cells were cotransfected
ith pBLCAT2, pBL1R, or pBL3R (5 mg) and either pCMV or pCMV Sm
20 mg) and harvested 48 h posttransfection as described in “Materials
nd Methods.” pBLCAT2 is the parental plasmid containing the tk
romoter upstream of the CAT gene and no EBV DNA sequences;
BL1R contains one copy of the 32-bp fragment in the 59-to-39 direction;
nd pBL3R contains three copies of the 32-bp fragment cloned in
andem 59 to 39. The activities are given relative to CAT activity in cells
otransfected with pBLCAT2 and the control CMV plasmid.
FIG. 3. Smbp-2 represses activated transcription. The EBV-negative
G75 cell line was cotransfected with p222 (1 mg) and either pCMV or
CMVSm (4 mg) by DEAE transfection with a previously described
echnique (Borras et al., 1996). Duplicate samples were split into two
ultures and resuspended in medium with or without TPA (20 ng/ml).
ells were harvested 48 h after transfection, and CAT activity was
etermined as described in “Materials and Methods.”ST control beads. To confirm the interaction between
mbp-2 and TBP, reciprocal experiments were also carried
ut using GST-TBP beads and in vitro transcribed and
ranslated Smbp-2. In these experiments, Smbp-2 bound to
ST-TBP beads but not to the GST control (Fig.5B). The
ontrol luciferase protein did not bind to either GST or
ST-TBP beads.
epression by Smbp-2 can be rescued by
verexpressed TFIIA
Several TBP-binding proteins have been identified as
ranscriptional repressors (Auble et al., 1994; Auble and
ahn, 1993; Boam et al., 1995; Fondell et al., 1996; Ge and
oeder, 1994; Goppelt et al., 1996; Jiang and Eberhardt,
996; Merino et al., 1993; Mermelstein et al., 1996; Poon et
l., 1994; Xiao et al., 1991; Yeung et al., 1997; Yeung et al.,
994; Zhang et al., 1996). Repression by any of these TBP-
inding proteins can be reversed by either TFIIA, TFIIB,
BP, or a combination of these GTFs. Experiments were
ext carried out to determine whether overexpression of
ne of these GTFs could overcome Smbp-2-mediated re-
ression of the BZLF1 promoter. Plasmids expressing ei-
her TFIIAa/b, TFIIAg, TFIIB, or TBP were cotransfected into
JAB cells with reporter plasmids and either Smbp-2 or the
ontrol CMV vector. The results of these experiments are
FIG. 4. Smbp-2 represses other promoters. The effect of Smbp-2 on
he activity of other promoters was tested through cotransfection of
ifferent promoters of viral and cellular origin with either pCMV or
CMVSm into BJAB cells as described in “Materials and Methods.” The
ifferent promoters tested in these experiments were three previously
ested BZLF1 promoter plasmids (p93, p79, and p40); four other viral
romoters, including the adenovirus E1B promoter (pBCAT), the SV40
romoter (pSVCAT), the CMV immediate-early 1 promoter (pIECAT), and
he EBV Fp promoter; and two mammalian promoters: the immunoglob-
lin heavy m chain promoter (pEmCAT) and the muscle creatine kinase
romoter (pMCKCAT). The results are shown as fold repression based
n the CAT activity seen in pCMVSm-transfected cells relative to the
AT activity in control pCMV-transfected cultures. The results shown
re based on the average of three independent experiments.
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164 ZHANG, WANG, AND MONTALVOhown in Fig 6. In these three plasmid transfection exper-
ments, the amount of repression by Smbp-2 was less than
reviously observed in the two plasmid transfections
hown in Fig. 1. Overexpressed TBP had no effect on either
he BZLF1 promoter or repression by Smbp-2. Overexpres-
ion of TFIIB alone repressed the BZLF1 promoter, and at
he lower concentration of TFIIB tested, additional repres-
ion was seen with Smbp-2. At the higher amount of TFIIB
ested, overexpression Smbp-2 had no effect on repression
y TFIIB. In contrast, repression by Smbp-2 was alleviated
y increasing amounts of TFIIAg or TFIIAa/b. Both TFIIAg
nd TFIIAa/b minimally activated (,0.5 fold) the BZLF1
FIG. 5. (A) Pull-down experiments were carried out with GST-Sm and ra
he in vitro translated product tested for binding to GST-Sm [TBP, TAFII55,
eactions. IP indicates input radiolabeled in vitro translation product used
eads containing GST-Sm. The TFIIA protein was made combining the se
ombined products to the GST or GST-Sm beads. Arrows point to the exp
DS–PAGE. The molecular mass standards are indicated in kDa at the rig
as analyzed on a 10% SDS–polyacrylamide gel, and that of TFIIA was
ull-down experiments for binding to GST-TBP. IP indicates input radiolabe
eads containing GST-TBP protein. Bound protein was analyzed on a 10%romoter. In cells transfected with 10 mg of the TFIIAa/b-
xpressing plasmid, repression by Smbp-2 was alleviated
y ;60%. In cells transfected with Smbp-2 and 10 mg of
FIIAg, the relative CAT activity was ;95% of the activity in
ontrol transfections (i.e., basal levels of BZLF1 promoter
ctivity).
mbp-2 disrupts TBP–TFIIA–TATA complex in
lectrophoretic mobility shift assay
Gel mobility shift experiments were next carried out to
etermine whether Smbp-2 affects the formation of the
led in vitro translated proteins as described in “Materials and Methods.”
ciferase (Luc), and TFIIA] are indicated at the top of each set of binding
ing reactions; GST, control beads containing GST protein; and GST-Sm,
n vitro translation of the a/b subunits and g subunit and then adding the
n vitro translated product. Bound products were eluted and subjected to
P and TFIIA profiles, respectively. Binding of TBP, TAFII55, ATF1, and Luc
d on a 12.5% gel. (B) In vitro translated Smbp-2 and Luc were tested in
itro translation product; GST, beads containing GST protein; and GST-TBP,
olyacrylamide gel. Molecular mass standards are indicated in kDa.diolabe
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165REPRESSION BY Smbp-2BP–TFIIA–DNA complex. The first set of experiments
ere performed using a probe that had the putative
ZLF1 promoter TATA box containing the sequence
TTAAA. The TTTAAA sequence has been shown to
unction as a TATA box, but the relative transcription
ctivity of promoters containing this sequence is re-
uced to 54% in HeLa cells and 62% in yeast, respec-
ively (Juo et al., 1996), compared with the consensus
ATA box sequence. To determine whether TBP could
nteract with the TTTAAA sequence, an oligonucleotide
panning 221 to 258 of the BZLF1 promoter (ZT) was
ynthesized, and binding with partially purified recombi-
ant His-tagged recombinant hTBP was first tested. No
pecific DNA–protein complexes were observed with
TBP alone. A nonspecific band (U; see below) was
onsistently detected with the TBP preparations. The
ddition of recombinant TFIIA to the binding reaction
aused the formation of two distinct DNA complexes
Fig. 7A). Neither of these complexes were seen in sam-
les containing TFIIA alone, suggesting that the ob-
erved DNA–protein complexes requires both TBP and
FIIA (Fig. 7A). When the mutant TATA box (mZT) probe
as tested under the same conditions, the TBP–TFIIA
omplex was not formed. The presence of TBP in the
FIG. 6. Smbp-2 mediated repression of the BZLF1 promoter can be
lleviated by TFIIA. Cotransfections were carried out with 2.5 mg of
222, 10 mg of pCMV (filled bars), or pCMVSm (open bars) and increas-
ng amounts (shown below graph) of plasmids expressing either
FIIAa/b (pCMVIIAa/b), TFIIAg (pCMVIIg), TFIIB (pCMVIIB), or TBP
pCMVTBP) (indicated above each graph). CAT activity was determined
s described in “Materials and Methods.” The relative activity was
etermined based on the CAT activity in samples containing p222 and
CMV control vector.NA–protein complexes was confirmed by competitive
inding experiments with cold oligonucleotides contain-
ng either TBP-binding sites or mutant TBP-binding sites.
he wild-type sequence from the BZLF1 promoter (ZT
robe) competed both bands, whereas no competition
as detected with a mutant oligonucleotide (mZT). Con-
istent with the presence of TBP in the DNA–protein
omplexes, an oligonucleotide containing the adenovi-
us E1B TATA box also competed both bands in these
xperiments, and the oligonucleotide T16C, which con-
ains a point mutation in the TATA box of T1B, competed
ess efficiently. Interestingly, some competition was seen
ith a mutant E1B sequence but only at 250 molar
xcess. The effect of purified Smbp-2 was then tested in
imilar experiments. GST-Sm alone bound to the ZT
robe. The addition of GST-Sm to the binding reaction
aused the disappearance of the lower TBP–TFIIA com-
lex (T*A9) and a supershift of the Sm band (Fig. 7B). The
ffect of Smbp-2 on the upper TFIIA–TBP–TATA box com-
lex was difficult to visualize because Smbp-2 binding to
he probe masked this region of the gel. Because it was
ifficult to determine whether there was a disruption of
he lower T*A9 complex, similar experiments were car-
ied out using the TIB probe, which contains the EIB TATA
ox sequence that has been used successfully by other
aboratories for TBP-binding studies (Ozer et al., 1996,
994). As previously reported (Ozer et al., 1994), the
ecombinant hTBP alone did not bind stably to the E1B
ATA box (Fig 7C). A specific TBP–TFIIA–E1B TATA box
omplex (T*A) was formed by the addition of TFIIA to the
inding reaction. This complex was competed by both
he homologous cold competitor and a competitor cor-
esponding to the BZLF1 TATA box (ZT; Fig. 7C). GST-Sm
lone bound to the T1B probe (Fig 7D). TFIIA had no effect
n binding of GST-Sm to the T1B probe. The addition of
ST-Sm to a binding reaction containing TBP and TFIIA
esulted in the loss of the T*A complex. Interestingly,
nder these conditions, GST-Sm also failed to bind the
NA. Similarly, GST-Sm failed to bind the DNA in the
resence TBP alone. These binding studies suggested
hat Smbp-2 has an inhibitory effect on the formation of
he TBP–TFIIA–TATA box complex and provided addi-
ional evidence of a protein–protein interaction between
mbp-2 and TBP.
DISCUSSION
The present study was initiated to identify proteins that
nteract with the ZI elements of the EBV BZLF1 promoter.
mbp-2 was initially cloned in our laboratory using the
1B and Z1C elements (Gulley et al., 1997), but we
iscovered during the course of this study that deletion
f the Z1A, Z1B, and Z1C elements had little effect on
mbp-2-mediated repression. Deletion of a 14-bp frag-
ent containing part of the Z1D element, however, sig-
ificantly affected the ability of Smbp-2 to repress the
ZLF1 promoter. The importance of this region for Smbp-
FIG. 7. (A) Competition for TBP binding to either the BZLF1 promoter TATA box (ZT) or a mutant BZLF1 promoter TATA box probe (mt ZT) by double-stranded
oligonucleotides competitors containing either the BZLF1 promoter TATA box (ZT), the mutant BZLF1 promoter TATA box (mt ZT), the adenovirus E1B TATA box (T1B),
or a mutant adenovirus E1B TATA box (T16C). The molar excess of each cold competitor is shown below each competitor. Purified recombinant TBP, recombinant
TFIIA, or both were used in the binding reactions as described in “Materials and Methods.” T*A and T*A9 indicate complexes formed with TBP–TFIIA in the binding
reactions. U indicates nonspecific binding activity present in TBP preparation. (B) The addition of partially purified GST-Sm causes disappearance of the T*A9
complex. Binding reactions were performed as described in “Materials and Methods” and contained either TBP, TFIIA, GST, or GST-Sm as indicated by the symbol
(1) above each lane. All proteins were added in equimolar amounts. S indicates complex formed by partially purified GST-Sm, and C indicates complex formed by
a protein that copurifies with GST. (C) Competition for TBP binding to the E1B TATA box probe (T1B) by cold competitors T1B, mutant E1B (T16C), or BZLF1 TATA (ZT).
The molar excess of each competitor is shown below. T*A indicates complex formed with TBP and TFIIA in the binding reaction, and V indicates a nonspecific band
present with preparations of TBP. (D) Smbp-2 disrupts the formation of the TBP–TFIIA–TATA box complex. Binding reactions were carried out with the E1B
TATA box probe (T1B) and TBP, TFIIA, GST, and GST-Sm as indicated by the symbol (1) above each lane. T*A indicates the TBP–TFIIA–TATA box complex;
V, a nonspecific binding seen with TPB preparation; S, Smbp-2–DNA complex; and C, a nonspecific binding activity present in GST preparations.
2-mediated repression was confirmed in heterologous
promoter experiments that demonstrated repression
could be transferred to another promoter containing the
DNA sequence from the BZLF1 promoter. Consistent
with our findings, a strong repressor site in the BZLF1
promoter immediately upstream of ZII, designated ZIIR,
has recently been described by other investigators
(Speck et al., 1997), but further studies are necessary to
determine whether ZIIR is the site for Smbp-2-mediated
repression.
Two distinct experiments in this study suggest that
Smbp-2 interacts with the general transcription factor
TBP. First, in pull-down assays, TBP specifically binds
GST-Smbp-2, and vice versa. Second, in electrophoretic
mobility shift assays with the E1B TATA box probe (Fig.
7D), the presence of TBP and Smbp-2 in the binding
reaction precludes nonspecific Smbp-2 binding as well
as the formation of the TBP–TFIIA–TATA box complex.
This suggests that protein–protein interactions between
TBP and Smbp-2 affect the ability of Smbp-2 to bind DNA.
The significance of the in vitro disruption of a stable
TBP–TFIIA–DNA complex by Smbp-2 is supported by in
vivo transfection experiments demonstrating that overex-
pressed TFIIAg and, to a lesser extent, the TFIIAa/b
subunit can overcome Smbp-2-mediated repression. The
TFIIA b and g subunits function in antirepression (Ma et
al., 1996), and it has been proposed that TFIIA can either
displace repressors associated with TBP or compete
with nonspecific DNA-binding proteins bound at the pro-
moter (Orphanides et al., 1996). The ability of TFIIA to
overcome Smbp-2-mediated repression may indicate
that TFIIA can displace Smbp-2 from TBP. Studies di-
rected at identifying the protein–protein interaction sites
in Smbp-2 and TBP should answer some of these ques-
tions.
Several TBP-binding proteins have been identified as
transcriptional repressors, including the MOT1–AD1–
TAF170 complex, TEF-1, Msx-1, HMG-1, DR2–TOPO1,
THR, NC1, and DR1–DRAP1 (NC2 b–NC2a) complex
(Auble et al., 1994; Auble and Hahn, 1993; Boam et al.,
1995; Fondell et al., 1996; Ge and Roeder, 1994; Goppelt
et al., 1996; Jiang and Eberhardt, 1996; Merino et al.,
1993; Mermelstein et al., 1996; Poon et al., 1994; Xiao et
al., 1991; Yeung et al., 1997; Yeung et al., 1994; Zhang et
al., 1996). These factors either destabilize TBP–TATA box
complex formation or affect interactions between TBP
and other basal initiation factors. For example, TEF-1 and
MOT1 inhibit TBP binding to the TATA box (Auble et al.,
1994; Auble and Hahn, 1993; Boam et al., 1995; Jiang and
Eberhardt, 1996; Poon et al., 1994; Xiao et al., 1991). In the
case of MOT1, inhibition is in an ATP-dependent manner
(Auble et al., 1994). The DR1–DRAP1 complex precludes
entry of TFIIA or TFIIB into the preinitiation complex
(Inostroza et al., 1992), and HMG-1 prevents TFIIB bind-
ing to TBP (Ge and Roeder, 1994). Smbp-2 appears to be
most like Dr1 in that the formation of a stable TBP–TFIIA–
TATA box complex in vitro is disrupted. However, repres-
sion of Dr1 is overcome by overexpression of TBP in vivo,
whereas overexpression TFIIA relieves Smbp-2-medi-
ated repression.
The effect of overexpressed Smbp-2 on the transcrip-
tional activity of various promoters has been investigated
by three different laboratories. In glial cells, overexpres-
sion of Smbp-2 causes transactivation of the JCV early
and late promoters (Chen et al., 1997). The Smbp-2-
binding site in the JCV genome is found in a region
containing a 98-bp repeat enhancer element called the B
domain (Chen et al., 1997). The B domain has bidirec-
tional enhancer/promoter activity that is glial specific
and is present in both the early and late promoters. In
HIT cells, a hamster insulinoma cell line, overexpression
of the hamster homolog of Smbp-2 (RIP-1) has a minimal
effect (at most 2-fold activation) on the RIPE3b element
that contains the Smbp-2-binding site in the rat insulin
promoter (Shieh et al., 1995). The RIPE3 element confers
b cell-specific expression when linked to a heterologous
promoter. Smbp-2 represses the EBV BZLF1 promoter in
BJAB cells and, to a lesser extent, in DG75 cells. Repres-
sion instead of activation is observed, but no B cell-
specific elements have been identified in the regulation.
Taken together, the results from three independent lab-
oratories suggest that cell-specific factors may affect or
contribute to transcriptional regulation by Smbp-2. Alter-
natively, the context of the Smbp-2-binding sites may
differentially affect transcription.
The ability of Smbp-2 to efficiently repress the BZLF1
promoter is dependent on a 14-bp region between 293
bp and 279 bp upstream of the transcription start site.
Within this 14-bp sequence is part of the Z1D element. In
addition, a recently described negative element desig-
nated ZIIR is found immediately upstream of the ZII
element and may represent the Smbp-2-binding site.
Smbp-2 also interferes with the formation of a stable
TBP–TFIIA–DNA complex. Based on these combined ob-
servations, our results suggest but do not prove that
Smbp-2 mediates repression by binding to the BZLF1
promoter and to TBP, preventing the interaction between
TBP and TFIIA and, thus subsequent assembly of the
transcription initiation complex. Numerous sequence-
specific single-stranded DNA-binding proteins have
been identified as both positive and negative regulators
of transcription (Duncan et al., 1994; Kamada and Miwa,
1992; Michelotti et al., 1995, 1996; Pan et al., 1990;
Swamynathan et al., 1998; Wilkison et al., 1990), so it is
entirely possible that Smbp-2 mediates its transcription
effects through single-stranded DNA binding. However,
despite numerous attempts to demonstrate specific
Smbp-2 binding to the 14-bp region using both single-
stranded and double-stranded DNA probes, we have
been unable to overcome high levels of nonspecific DNA
binding by Smbp-2 in gel mobility shift assays (data not
shown). Thus it cannot be ruled out that Smbp-2 may
interact with another DNA-binding protein that tethers
Smbp-2 to the promoter, but there is no evidence for this
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model. Further studies are clearly necessary to delineate
the mechanism used by Smbp-2 to repress the BZLF1
promoter and to assess the contribution of Smbp-2 to the
maintenance of EBV latency.
MATERIALS AND METHODS
Cell lines and oligonucleotides
The human B cell lines BJAB and DG75 were grown
and maintained in RPMI 1640 containing 0.002 M glu-
tamine, penicillin (100 U/ml), streptomycin (100 mg/ml).
and 10% fetal bovine serum. All cells were grown at 37°C
and 10% CO2.
Synthetic oligonucleotides were synthesized in a
Beckman oligonucleotide synthesizer at University of
Texas Health Science Center at San Antonio or pur-
chased from Genosys Inc. (Woodlands, TX). The follow-
ing oligonucleotides and their corresponding DNA
sequence were used in this study: ZT, 59-ACAGAGGAG-
GCTGGTGCCTTGGCTTTAAAGGGGAGATG-39 and
39-GTCTCCTCCGACCACGGAACCGAAATTTCCCCT-
CTACA-59; mZT, 59-ACAGAGGAGGCTGGTGCCT-
TGGCTCGGCAGGGGAGATG-39 and 39-GTCTCCTC-
CGACCACGGAACCGAGCCGTCCCCTCTACA-59; T1B,
59-TCGACTTAAAGGGTATATAATGCGCCGTG-39 and 39-
GAATTTCCCATATATTACGCGGCACAGCT-59; T16C, 59-
TCGACTTAAAGGGTACATAATGCGCCGTG-39 and 39-
GAATTTCCCATGTATTACGCGGCACAGCT-59; and ZR, 59-
AGACACACCTAAATTTAGCACGTCCCAAACCA-39 and
39-CTGTGTGGATTTAAATCGTGCAGGGTTTGGAT-59.
Plasmids
pGEX4T3 and pGEX3X were purchased from Pharma-
cia. pGST-Sm was constructed by inserting the 4.3-kb
open reading frame of Smbp-2 into the NotI sites of the
pGEX4T3. pGST-Sm2.2 contains amino acids 132–861 of
Smbp-2 cloned into the EcoRI site of pGEX3X. pGST-
Sm1.4 contains amino acids 387–861 cloned into
pGEX3X. pCMVSm was made by cloning the 4.3-kb Sm-
bp2 cDNA into the HindIII–XbaI sites pCMV (kindly pro-
vided by Dr. Wen-Hwa Lee, The University of Texas
Heath Science Center at San Antonio). p222, p130, and
p98 were constructed in our laboratory and have been
previously reported (Montalvo et al., 1995). For construc-
tion of p40, the 240-to-19 sequence of the BZLF1 pro-
moter was obtained by polymerase chain reaction and
inserted into the BamHI–SmaI site of pCAT. pBL1R con-
tains one copy of the oligonucleotide ZR cloned 59 to 39
into the BamHI site of pBLCAT2 (Luckow and Schultz,
1987), and pBL3R contains three copies of ZR cloned in
tandem 59 to 39 into the BamHI site of pBLCAT2.
pGEX-hTBP, pGEMIIB, and pKB104 were kindly pro-
vided by Dr. Ed Seto (University of South Florida, Tampa).
pCMVIIAa/b, pCMVIIAg, and pCMVIIB were kindly pro-
vided by Dr. Danny Reinberg (UMDNJ, Piscataway, NJ)
pH6TBP, pQEIIAa pQEIIAb, and pQEIIAg were gener-
ously provided by Dr. Paul Lieberman (Wistar Institute,
Philadelphia, PA).
B cell transfections and CAT Assays
BJAB cells (3 3 106) were transfected with DNA by
electroporation at 220 V and 960 mF. DG75 cells were
transfected according to the DEAE–dextran method as
previously described (Borras et al., 1996). After 48 h, the
cells were harvested, and lysates were prepared as
previously described (Wang et al., 1997). CAT activity and
transfection efficiencies were determined as previously
described (Wang et al., 1997).
Protein purification
For purification of GST-Sm, bacteria containing either
pGST4T3 or pGST-Sm were grown at 37°C and induced
with 0.1 mM isopropyl b-D-thiogalactoside (IPTG). After
the addition of IPTG, cells were grown for an additional
7 h at 30°C. Bacteria were harvested, resuspended in 50
ml of PBS containing protease inhibitor cocktail (1 mM
PMSF, 1 mM benzamide–HCl, 0.4 mg/ml aprotinin, 0.5
mg/ml leupeptin, 0.7 mg/ml pepstatin) and 0.2% Nonidet
P-40, and lysed by sonication. Lysates were centrifuged
at 30,000g for 30 min at 4°C. The supernatant was mixed
with 2 ml of 50% glutathione agarose beads (Pharmacia)
at 4°C for 30 min, and beads were washed four times
with cold PBS. Bound protein was eluted with 15 mM
glutathione in elution buffer (50 mM Tris–HCl, pH 8.0, 100
mM KCl, 1 mM dithiothrietol). The proteins were dialyzed
versus Dignam D (20 mM HEPES, pH 7.9, 20% glycerol,
100 mM KCl, 0.2 mM EDTA, 0.5 mM PMSF, and 0.5 mM
DTT) and stored at 280°C. The purification of histidine-
tagged TBP, TFIIAa, TFIIAb, and TFIIAg has been de-
scribed previously (Ozer et al., 1994). Purified TFIIAa,
TFIIAb, and TFIIAg were mixed at an equal molar ratio
under denaturing conditions and subsequently renatured
by dialysis against Dignam D buffer.
Pull-down assay
Bacterial lysates containing overexpressed GST fusion
protein were made as described above. After centrifuga-
tion, 1 ml of cleared lysate supernatant was mixed with
40 ml of glutathione-agarose beads at 4°C for 30 min and
washed three times with cold PBS. The beads were then
mixed with 2–10 ml of in vitro translated 35S-methionine-
labeled protein and 0.5 ml of pull-down binding buffer (50
mM Tris–HCl, pH 7.7, 120 mM NaCl, 0.05% Nonidet P-40,
4% BSA, and protease inhibitor cocktail) and incubated
with agitation at 4°C for 1 h. After incubation, the beads
were washed five times with pull-down binding buffer,
and bound protein was eluted by boiling in SDS loading
buffer. Samples were then subjected to SDS–PAGE and
analyzed by autoradiography.
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Electrophoretic mobility shift assay
Radioactive probes were made as described previ-
ously (Wang et al., 1997). Binding reactions were carried
out at 30°C for 1 h in 12-ml volume containing 12 mM
HEPES, 60 mM KCl, 10% glycerol, 5 mM MgCl2, 0.05%
Nonidet P-40, 1 mM dithiothreitol, 25 mg/ml poly(dGdC/
dGdC), 50 mg/ml BSA, 0.5 mM EDTA, 10 fmol of probe,
and ;0.2 mM protein. After incubation, the mixture was
loaded onto a 5% acrylamide gel (19.2 acrylamide/0.8
bisacrylamide) in 0.089 M Tris–HCl, pH 8.3, 0.089 M boric
acid, 1 mM EDTA, and 5 mM Mg acetate. Gels were
electrophoresed at 100 V, dried, and autoradiographed
with intensifying screen at 270°C.
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